MannKind Corporation to Participate in the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/01/22
MannKind Corp (MNKD) CEO Michael Castagna on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022GlobeNewsWire • 08/02/22
Mannkind to Host Product Theater and Booth at the American Diabetes Association's 82nd Scientific Sessions in New Orleans, June 3-7GlobeNewsWire • 06/03/22
MannKind's Technosphere® Inhalation Platform Utilized in FDA-Approved Tyvaso DPI™GlobeNewsWire • 05/24/22
MannKind Corporation Announces Agreement to Acquire V-Go® Insulin Delivery Device From Zealand PharmaGlobeNewsWire • 05/17/22
MannKind Corporation (MNKD) CEO Michael Castagna on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/06/22
MannKind Corporation to Hold 2022 First Quarter Financial Results Conference Call on May 5, 2022GlobeNewsWire • 04/28/22
MannKind Presents Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30GlobeNewsWire • 04/27/22
MannKind Corporation to Participate in the Lytham Partners Spring 2022 Investor ConferenceGlobeNewsWire • 03/28/22
MannKind Corporation to Participate in the Cantor Virtual Rare Orphan Disease SummitGlobeNewsWire • 03/22/22
MannKind Corporation to Participate in Oppenheimer 32nd Annual Healthcare ConferenceGlobeNewsWire • 03/08/22
MannKind's (MNKD) CEO Michael Castagna on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/25/22
MannKind Corporation Reports 2021 Fourth Quarter and Full Year Financial ResultsGlobeNewsWire • 02/24/22
MannKind Corporation to Hold 2021 Fourth Quarter and Full Year Financial Results Conference Call on February 24, 2022GlobeNewsWire • 02/21/22